CDC26P1

Across TCGA pan-cancer cohorts, CDC26P1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CDC26P1’s most consistent transcriptional readouts.

The strongest signal is observed in kidney chromophobe (KICH), where CDC26P1 RNA is repressed in tumor relative to normal tissue. In most cancer types CDC26P1 is over-expressed in tumor, although a few such as KICH show the opposite, repressed pattern.

KICH, BRCA, and ESCA are the cancer types where CDC26P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CDC26P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KICH	All	All	−0.785	.035	2	view →
BRCA	All	IV	+0.715	<.001	2	view →
ESCA	All	All	+0.973	.020	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CDC26P1–KICH

Open the KICH breakdown →